Table 5 Time trend in aAARs of NOS over the period 1993–2017 by sex (Standard: Europe 2013).
From: Epidemiology of malignant brain tumors in Genova, Italy. 1993–2017
Period | Male | Female | Both sexes | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. | CR | AAR | 95%CI | No. | CR | AAR | 95%CI | No. | CR | AAR | 95%CI | |
1993–1995 | 27 | 2.05 | 2.76 | 1.63–3.90 | 27 | 1.82 | 2.26 | 1.40–3.13 | 54 | 1.93 | 2.54 | 1.83–3.24 |
1996–1998 | 29 | 2.25 | 4.02 | 2.43–5.63 | 39 | 2.70 | 3.04 | 2.06–4.02 | 68 | 2.49 | 3.38 | 2.54–4.22 |
1999–2001 | 36 | 2.87 | 4.65 | 2.97–6.34 | 36 | 2.55 | 2.87 | 1.91–3.84 | 72 | 2.70 | 3.55 | 2.70–4.41 |
2002–2004 | 24 | 1.95 | 3.01 | 1.71–4.32 | 39 | 2.80 | 3.13 | 2.14–4.12 | 63 | 2.40 | 3.11 | 2.32–3.90 |
2005–2007 | 27 | 2.19 | 3.24 | 1.88–4.60 | 36 | 2.59 | 2.75 | 1.84–3.66 | 63 | 2.40 | 2.91 | 2.17–3.66 |
2008–2010 | 30 | 2.44 | 3.23 | 1.99–4.47 | 36 | 2.61 | 2.59 | 1.72–3.45 | 66 | 2.53 | 2.87 | 2.15–3.58 |
2011–2013 | 33 | 2.69 | 3.78 | 2.43–5.12 | 34 | 2.47 | 2.52 | 1.67–3.37 | 67 | 2.58 | 3.03 | 2.30–3.76 |
2014–2017 | 52 | 3.23 | 4.58 | 3.31–5.85 | 48 | 2.68 | 2.67 | 1.91–3.43 | 100 | 2.94 | 3.39 | 2.73–4.05 |
Total | 258 | 2.48 | - | - | 295 | 2.53 | - | - | 553 | 2.51 | - | - |
3YMPV | - | - | 3.0 | –4.1/10.6 | - | - | –0.7 | –4.6/3.3 | - | - | 0.8 | –3.3/5.1 |